Washington Trust’s Medicines Co MDCO Stock Holding History

Washington Trust’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-2,500	Closed	-$92K	–	936
2018 Q2	$92K	Buy	+2,500	New	+$81.2K	﹤0.01%	331

Other funds holding MDCO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Washington Trust's MDCO Position: Q3 2018 in Review

Washington Trust sold out of Medicines Co (MDCO) in Q3 2018, closing a stake of 2,500 shares — an estimated $92K sold.

Washington Trust first reported a position in MDCO in Q2 2018 and held it in 1 quarter. The position peaked at $92K in Q2 2018. 184 funds tracked by Wall St. Rank hold MDCO as of Q3 2018.

Washington Trust reported no remaining Medicines Co position as of Q3 2018 after selling out during the quarter.
Washington Trust sold 2,500 Medicines Co shares in Q3 2018, an estimated $92K.
Washington Trust first reported a position in Medicines Co in Q2 2018 and held it in 1 quarter.
Washington Trust's Medicines Co position peaked at $92K in Q2 2018.
184 funds tracked by Wall St. Rank held Medicines Co as of Q3 2018.

Based on Washington Trust's 13F filing for Q3 2018, filed 13 Nov 2018.